FIM
TMO icon

Freedom Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Freedom Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,928
Closed -$1.59M – 656
2025
Q2 		$1.59M Buy
3,928
+572
+17% +$239K 0.13% 141
2025
Q1 		$1.67M Sell
3,356
-335
-9% -$181K 0.14% 129
2024
Q4 		$1.92M Buy
3,691
+364
+11% +$200K 0.16% 111
2024
Q3 		$2.06M Sell
3,327
-916
-22% -$542K 0.16% 112
2024
Q2 		$2.35M Sell
4,243
-64
-1% -$36.7K 0.19% 89
2024
Q1 		$2.5M Sell
4,307
-412
-9% -$231K 0.2% 88
2023
Q4 		$2.51M Sell
4,719
-362
-7% -$175K 0.2% 88
2023
Q3 		$2.57M Sell
5,081
-2,361
-32% -$1.26M 0.31% 65
2023
Q2 		$3.88M Sell
7,442
-525
-7% -$283K 0.44% 39
2023
Q1 		$4.59M Sell
7,967
-870
-10% -$490K 0.52% 31
2022
Q4 		$4.87M Sell
8,837
-480
-5% -$254K 0.55% 28
2022
Q3 		$4.73M Buy
9,317
+100
+1% +$56K 0.54% 28
2022
Q2 		$5.01M Sell
9,217
-2,750
-23% -$1.51M 0.53% 30
2022
Q1 		$7.07M Buy
11,967
+2,951
+33% +$1.7M 0.63% 18
2021
Q4 		$6.02M Buy
9,016
+70
+0.8% +$43.7K 0.44% 39
2021
Q3 		$5.11M Sell
8,946
-1,224
-12% -$672K 0.39% 43
2021
Q2 		$5.13M Buy
10,170
+251
+3% +$118K 0.38% 45
2021
Q1 		$4.53M Sell
9,919
-1,224
-11% -$584K 0.35% 56
2020
Q4 		$5.19M Buy
11,143
+1,808
+19% +$848K 0.57% 35
2020
Q3 		$4.12M Buy
9,335
+166
+2% +$68.6K 0.45% 44
2020
Q2 		$3.32M Sell
9,169
-2,744
-23% -$920K 0.36% 58
2020
Q1 		$3.89M Sell
11,913
-107
-0.9% -$33.7K 0.34% 63
2019
Q4 		$3.9M Buy
12,020
+196
+2% +$59.4K 0.34% 62
2019
Q3 		$3.44M Buy
11,824
+1,819
+18% +$521K 0.3% 60
2019
Q2 		$2.94M Sell
10,005
-2,265
-18% -$624K 0.25% 80
2019
Q1 		$3.36M Buy
12,270
+2,099
+21% +$522K 0.27% 72
2018
Q4 		$2.28M Sell
10,171
-2,872
-22% -$674K 0.18% 102
2018
Q3 		$3.08M Buy
13,043
+3,956
+44% +$910K 0.19% 85
2018
Q2 		$1.88M Sell
9,087
-2,605
-22% -$553K 0.11% 179
2018
Q1 		$2.41M Sell
11,692
-626
-5% -$131K 0.12% 135
2017
Q4 		$2.34M Sell
12,318
-2,073
-14% -$397K 0.12% 126
2017
Q3 		$2.72M Buy
14,391
+768
+6% +$139K 0.15% 85
2017
Q2 		$2.38M Buy
13,623
+1,466
+12% +$246K 0.14% 95
2017
Q1 		$1.87M Buy
12,157
+272
+2% +$41.6K 0.11% 133
2016
Q4 		$1.68M Sell
11,885
-376
-3% -$55.4K 0.11% 129
2016
Q3 		$1.95M Sell
12,261
-955
-7% -$147K 0.12% 97
2016
Q2 		$1.95M Buy
13,216
+2,069
+19% +$305K 0.13% 84
2016
Q1 		$1.58M Sell
11,147
-68
-0.6% -$9.11K 0.11% 115
2015
Q4 		$1.59M Sell
11,215
-7,379
-40% -$984K 0.12% 115
2015
Q3 		$386K Buy
18,594
+10,324
+125% +$1.35M 0.04% 398
2015
Q2 		$1.07M Buy
8,270
+858
+12% +$112K 0.11% 142
2015
Q1 		$996K Buy
7,412
+652
+10% +$84.1K 0.11% 138
2014
Q4 		$847K Buy
6,760
+873
+15% +$106K 0.11% 163
2014
Q3 		$716K Buy
5,887
+661
+13% +$80.4K 0.13% 155
2014
Q2 		$617K Buy
5,226
+158
+3% +$18.6K 0.1% 179
2014
Q1 		$609K Sell
5,068
-736
-13% -$87.5K 0.13% 143
2013
Q4 		$646K Buy
5,804
+540
+10% +$53.7K 0.16% 116
2013
Q3 		$485K Buy
5,264
+842
+19% +$76.1K 0.14% 124
2013
Q2 		$374K Buy
+4,422
New +$368K 0.13% 140

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Freedom Investment Management's TMO Position: Q3 2025 in Review

Freedom Investment Management sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 3,928 shares — an estimated $1.59M sold.

Freedom Investment Management first reported a position in TMO in Q2 2013 and held it in 49 quarters. The position peaked at $7.07M in Q1 2022. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Freedom Investment Management reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Freedom Investment Management sold 3,928 Thermo Fisher Scientific shares in Q3 2025, an estimated $1.59M.
  • Freedom Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 49 quarters.
  • Freedom Investment Management's Thermo Fisher Scientific position peaked at $7.07M in Q1 2022.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Freedom Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.